CALC · CalciMedica Inc
United States · RS rating 47 · As of 2026-10-14
| Price | 1.07 USD |
|---|---|
| 1-day change | -4.5% |
| RS rating (overall / 1M / 3M / 12M) | 47 / 3 / 96 / 9 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 25 / 22 / 37 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -250.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +84.1% |
| Market cap (USD) | $9.1M |